Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma

Creative Commons License

TURAN N., Benekli M., Unal O. U., Unek I. T., Tastekin D., Dane F., ...Daha Fazla

CHINESE JOURNAL OF CANCER RESEARCH, cilt.27, sa.4, ss.408-416, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 4
  • Basım Tarihi: 2015
  • Doi Numarası: 10.3978/j.issn.1000-9604.2015.08.03
  • Dergi Adı: CHINESE JOURNAL OF CANCER RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.408-416
  • Anahtar Kelimeler: Pancreatic adenocarcinoma, adjuvant chemotherapy (adjuvant CT), adjuvant radiotherapy, SINGLE-INSTITUTION EXPERIENCE, RANDOMIZED CONTROLLED-TRIAL, SEER REGISTRY DATA, PHASE-III, RADIATION-THERAPY, FOLINIC ACID, CANCER, CHEMOTHERAPY, RADIOTHERAPY, GEMCITABINE
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: We examined the impact of adjuvant modalities on resected pancreatic and periampullary adenocarcinoma (PAC).